As pharma companies wrestle with how and when to use wearables and other digital technologies to measure how their experimental drugs impact patients, clinical research giant Icon has acquired ...

Road-tripping through southern Minnesota? Keep an eye out for a 55-foot-tall legend. The Jolly Green Giant has been smiling over highways, small towns, and photo ops for nearly a century. Here’s how ...

Yet another CRO giant has taken a revenue hit due to a customer demand dip. Irish clinical research organization Icon reported third-quarter revenue of $2.03 billion, underperforming analyst ...

CRO giant Icon is partnering with Saphetor, which specializes in large-scale identification and interpretation of human genetic variants, to develop new approaches for clinical trials focused on ...